Showing 1 - 6 results of 6 for search 'Michal Kantecki', query time: 0.03s Refine Results
  1. 1
    In vitro activity of aztreonam-avibactam and comparators against Metallo-β-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016–2020

    In vitro activity of aztreonam-avibactam and comparators against Metallo-β-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016–2020 by Gian Maria Rossolini, Francis F. Arhin, Michal Kantecki

    Published 2024-03-01
    Get full text
    Article
  2. 2
    Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019

    Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019 by Eric Utt, Michal Kantecki, Guillermo Cabezas-Camarero, Susanna Esposito

    Published 2023-06-01
    Get full text
    Article
  3. 3
    In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019

    In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019 by Gian Maria Rossolini, Gregory Stone, Michal Kantecki, Francis F. Arhin

    Published 2022-09-01
    Get full text
    Article
  4. 4
    Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016–2020

    Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS P... by Denis Piérard, Elizabeth D. Hermsen, Michal Kantecki, Francis F. Arhin

    Published 2023-11-01
    Get full text
    Article
  5. 5
    Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam

    Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized... by Miguel Sánchez-García, Jennifer Hammond, Jean Li Yan, Michal Kantecki, Wajeeha Ansari, Matthew Dryden

    Published 2020-06-01
    Get full text
    Article
  6. 6
    Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials

    Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials by Matthew Dryden, Michal Kantecki, Jean Li Yan, Gregory G. Stone, Heidi Leister-Tebbe, Mark Wilcox

    Published 2022-03-01
    Get full text
    Article

Search Tools: